CJC-1295 (no DAC) + Ipamorelin

Description

Each vial contains 5mg of CJC-1295 and 5mg of Ipamorelin in a precise 1:1 ratio. CJC-1295 without DAC has a short half-life of around 30 minutes, making it better suited for research into pulsatile GH release. This pattern more closely reflects the body’s natural rhythm, though it requires more frequent dosing compared to the longer-lasting DAC version. Ipamorelin is a growth hormone secretagogue (GHS) and selective ghrelin receptor agonist. It triggers GH release in a targeted way without significantly affecting cortisol, prolactin, or other hormones. Like CJC-1295, Ipamorelin is often studied for its potential roles in muscle development, fat loss, recovery, and healthy aging. When CJC-1295 (No DAC) and Ipamorelin are combined, they work synergistically by stimulating GH release through complementary pathways. This pairing promotes a natural, controlled rise in growth hormone levels, potentially amplifying the effects of each compound while maintaining physiological balance.